Compliance and patient reported toxicity from oral adjuvant bisphosphonates in patients with early breast cancer. A cross sectional study
Author:
Funder
Weston Park Cancer Charity
Publisher
Elsevier BV
Subject
Oncology
Reference28 articles.
1. Exploring the anti-tumour activity of bisphosphonates in early breast cancer;Winter;Cancer Treat. Rev.,2008
2. Antitumor effects of clinical dosing regimens of bisphosphonates in experimental breast cancer bone metastasis;Daubine;J. Natl. Cancer Inst.,2007
3. Preclinical models of bone metastases;Mundy;Semin. Oncol.,2001
4. Metastasis to bone: causes, consequences and therapeutic opportunities;Mundy;Nat. Rev. Cancer,2002
5. Reduction in new metastases in breast cancer with adjuvant clodronate treatment;Diel;N. Engl. J. Med.,1998
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Adjuvant bisphosphonate use in patients with early stage breast cancer: Patient perspectives on treatment acceptability and potential de-escalation;Journal of Bone Oncology;2021-04
2. Long noncoding RNA CERS6‐AS1 functions as a malignancy promoter in breast cancer by binding to IGF2BP3 to enhance the stability of CERS6 mRNA;Cancer Medicine;2019-11-08
3. Clinical benefits of bone targeted agents in early breast cancer;The Breast;2019-11
4. Highlights of the 16th St Gallen International Breast Cancer Conference, Vienna, Austria, 20–23 March 2019: personalised treatments for patients with early breast cancer;ecancermedicalscience;2019-04-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3